Neovasc Inc. buy marge
Start price
16.10.18
/
50%
€563.75
Target price
16.04.19
€902.00
Performance (%)
-83.00%
End price
16.04.19
€95.84
Summary
This prediction ended on 16.04.19 with a price of €95.84. The BUY prediction by marge for Neovasc Inc. performed very badly with a performance of -83.00%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neovasc Inc. | - | - | - | - |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by marge for this prediction
In the thread Neovasc Inc diskutieren
marge stimmt der Buy-Einschätzung von Thorsten_78 zu
10.10.2018 Neovasc announces that the FDA has granted Breakthrough Device designation to the Neovasc Reducer, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the U.S.
(Laufzeit überschritten)